This compound is a halogenated heterocyclic compound used as an intermediate in pharmaceutical manufacturing. It features a morpholine ring attached to a pyridine core substituted with bromine and chlorine atoms.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1199773-09-5
4-amino-6-tert-butyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one
Pharmaceutical intermediate compound
2-(2-Nitrovinyl)thiophene
Pharmaceutical intermediate compound
4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine
Pharmaceutical intermediate compound
N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
Pharmaceutical intermediate compound
(1S,5R)-8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Ol
pharmaceutical intermediate
Ethyl N-piperazinecarboxylate
pharmaceutical intermediate
4-((5,6-Dimethoxy-1-oxoindan-2-yl)methyl)piperidine hydrochloride
pharmaceutical intermediate
10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
Chelating agent intermediate for MRI contrast agents
4-(5-bromo-3-chloro-2-pyridinyl)morpholine
RIPNXWDOUNUVSM-UHFFFAOYSA-N
C1COCCN1C2=C(C=C(C=N2)Br)Cl
—